Pancreatic Tumors May Require a One-Two-Three Punch

One of the many difficult things about pancreatic cancer is that tumors are resistant to most treatments because of their unique density and cell composition. However, in a new Wilmot Cancer Institute study, scientists discovered that a three-drug combination can simultaneously target the cancer cells as well as the other harmful, inflammatory cells within the tumor, to improve survival.
Source: University of Rochester Medical Center Press Releases - Category: Universities & Medical Training Authors: Source Type: news